Core Insights - Merus NV's shares increased by 38.2% to $95.21 following Genmab's announcement of an $8 billion all-cash acquisition deal, which includes the addition of the breakthrough therapy Petosemtamab to Genmab's late-stage pipeline [1] Gainers - Steakholder Foods Ltd rose 92% to $8.32 after announcing an agreement to acquire Twine Solutions [4] - JFB Construction Holdings surged 77.4% to $12.15 following a $44 million private placement announcement [4] - Plus Therapeutics gained 24.3% to $0.77 after securing a national coverage agreement with UnitedHealthcare for its CNSide assay [4] - Avalo Therapeutics rose 24.1% to $13.40 after a previous decline of 6% [4] - Enanta Pharmaceuticals gained 22.7% to $9.69 ahead of presenting topline results from its Phase 2b study of Zelicapavir for RSV [4] - Canopy Growth Corp jumped 19.4% to $1.60 [4] - Zura Bio Ltd gained 18.3% to $2.85 after a 15% increase on Friday [4] - Tilray Brands surged 17.4% to $1.35, with first-quarter financial results to be announced on October 9 [4] - Larimar Therapeutics jumped 16.4% to $5.93, with an update on the Nomlabofusp program scheduled for September 2 [4] Losers - MoonLake Immunotherapeutics dipped 86.3% to $8.50 despite achieving statistically significant results in its Phase 3 VELA trials [4] - Maris Tech fell 37.3% to $2.62 after reporting a H1 loss of 30 cents per share [4] - Sunrise New Energy Co Ltd shares dipped 28.1% to $0.88 after a previous 10% gain [4] - Cycurion Inc declined 15.5% to $0.28 after a significant drop of over 30% on Friday [4] - bioAffinity Technologies dipped 14.4% to $4.53 after a 55% increase on Friday [4] - Youxin Technology Ltd fell 13.9% to $0.058 following a 1-for-80 reverse split announcement [4] - Top KingWin Ltd declined 12.8% to $4.07 after a previous 48% increase [4] - Cellectis SA fell 10.4% to $3.01 [4] - Quantum-Si Inc decreased 10.1% to $1.34 after filing for a mixed shelf of up to $300 million [4] - Penguin Solutions Inc fell 8.4% to $24.00 [4]

Market Overview - U.S. stocks traded lower, with the Nasdaq Composite falling more than 1% on Thursday, while the Dow decreased by 0.50% to 45,889.75 and the S&P 500 dropped 0.94% to 6,575.35 [1] - Consumer staples shares increased by 0.5% on Thursday, contrasting with a 1.5% decline in communication services stocks [1][2] Economic Indicators - Initial jobless claims decreased by 14,000 to 218,000 in the third week of September, better than market estimates of 235,000 [3][12] - U.S. wholesale inventories fell by 0.2% month-over-month to $898.8 billion in August, against expectations of a 0.1% increase [12] - Durable goods orders rose by 2.9% month-over-month to $312.1 billion in August, surpassing market estimates of a 0.5% decline [12] - The U.S. trade deficit in goods narrowed by $17.3 billion to $85.5 billion in August, compared to market estimates of $95.65 billion [12] - The U.S. economy grew at an annualized rate of 3.8% in the second quarter, an increase from the previous estimate of 3.3% [12] Commodity Market - Oil prices decreased by 0.5% to $64.66, while gold fell by 0.1% to $3,766.60 [6] - Silver prices increased by 1.4% to $44.805, whereas copper declined by 0.6% to $4.7865 [6] Company Performance - PepGen Inc. shares surged 107% to $5.51 following the announcement of a $100 million public offering priced at $3.20 per share [10] - SciSparc Ltd. shares rose 79% to $6.86 after announcing a quantum computing-enabled 3D protein modeling initiative [10] - Plus Therapeutics, Inc. shares increased by 40% to $0.5640 due to a national coverage agreement with UnitedHealthcare [10] - SeaStar Medical Holding Corporation shares plummeted 50% to $0.6226 after a recommendation to continue a pivotal trial [10] - Erayak Power Solution Group Inc. shares fell 31% to $0.0493 after a previous jump [10] - Cemtrex, Inc. shares dropped 29% to $0.4470 following the approval of a reverse stock split [10]